Not exact matches
The falling rate of
cancer - related deaths is clearly an impressive achievement, and may be partially attributable to drug makers» increased focus on developing
novel new
therapies to fight
cancers.
His work indicates that this cell surface marker could serve as a target for a
novel brain
cancer vaccine or T - cell
therapies engineered to recognize and kill tumors carrying that neoantigen.
A spin - off from Queen's University 7 years ago, the drug discovery and development company develops
novel cytochrome P450s to generate improved
therapies for skin diseases and
cancer.
«Ultimately, understanding the interplay between genetic mutations, gut microbes, and inflammation may lead to
novel diagnostics and
therapies for intestinal
cancer.»
«It is anticipated that this
novel compound will have significant efficacy in human melanomas and other
cancers either as a stand - alone
therapy or in combination with other targeted or immune - based
therapies,» explained co-corresponding author Rhoda Alani, MD, the Herbert Mescon Chair of Dermatology at Boston University School of Medicine (BUSM).
«Researchers identify
novel mechanism in combination drug
therapy for acute myeloid leukemia, other
cancers.»
Researchers at The University of Texas MD Anderson
Cancer Center developed a
novel chimeric mouse model to test the combination
therapy using immune checkpoint blockades with
therapies targeting myeloid - derived suppressor cells (MDSCs).
He hopes that further studies may identify
novel approaches to immune - based
cancer therapy or reveal new drug targets for inflammatory diseases.
This is important because it makes it possible to model almost any autoimmune disease, evaluate new drug
therapies, and even identify
novel targets in the emerging area of
cancer immunotherapies.
Physical chemist Bartosz Grzybowski of Northwestern University in Evanston, Illinois, and colleagues hit upon the droplets while trying to devise
novel cancer therapies.
The integrated approaches being developed and used at Moffitt are instrumental for the continued advancement of our understanding of
cancer progression and the development of
novel cancer therapies.
In a letter to the New England Journal of Medicine, a Massachusetts General Hospital (MGH) research team reports a remarkable treatment response in a patient participating in a clinical trial of a
novel immune - system - based
cancer therapy.
Meanwhile, his research teams are moving several other
novel therapies toward clinical trials, each of which has potential for use in the synergistic model of
cancer treatment that Black believes will offer the best hope for his patients.
The study, «Non-toxic metabolic management of metastatic
cancer in VM mice:
novel combination of ketogenic diet, ketone supplementation, and hyperbaric oxygen
therapy,» was published online today in PLOS ONE.
A team of researchers from the Hyperbaric Biomedical Research Laboratory at the University of South Florida (USF) doubled survival time in an aggressive metastatic
cancer model using a
novel combination of non-toxic dietary and hyperbaric oxygen
therapies.
«Nanoparticles combine photodynamic and molecular
therapies against pancreatic
cancer:
Novel drug - delivery system cuts off common treatment escape pathways in animal models.»
Schiffman plans to use what he's learned in elephants as a strategy for developing
novel cancer - fighting
therapies.
It's the first CAR - T
therapy to come before the FDA, leading a pack of
novel treatments that promise to change the standard of care for certain aggressive blood
cancers.
Investigators with The
Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in the subclassification of the disease and may help target therapies that are most appropriate for each pa
Cancer Genome Atlas (TCGA) Research Network have identified
novel genomic and molecular characteristics of cervical
cancer that will aid in the subclassification of the disease and may help target therapies that are most appropriate for each pa
cancer that will aid in the subclassification of the disease and may help target
therapies that are most appropriate for each patient.
Timothy Wang at Columbia recently published work in
Cancer Cell (DOI: 10.1016 / j.ccell.2016.11.005) that showed that recruitment of nerves into the tumor microenvironment is necessary and sufficient for stomach cancer progression, and that blocking a neurotransmitter in the nerves that line the stomach could represent a novel th
Cancer Cell (DOI: 10.1016 / j.ccell.2016.11.005) that showed that recruitment of nerves into the tumor microenvironment is necessary and sufficient for stomach
cancer progression, and that blocking a neurotransmitter in the nerves that line the stomach could represent a novel th
cancer progression, and that blocking a neurotransmitter in the nerves that line the stomach could represent a
novel therapy.
These
therapies could enhance the effects of
novel cancer immunotherapies when used in combination, resulting in better health outcomes for
cancer patients.
«A better understanding of how inflammation affects stem cells and other components of tissue will revolutionize our understanding of many diseases, including
cancer, and likely lead to
novel therapies,» Naik says.
Coupled with a review of these results by experts on a molecular tumor board, the opportunity exists to identify
novel therapies that would target specific abnormalities,» notes senior author of the work, Shridar Ganesan, MD, PhD, associate director for translational science at Rutgers
Cancer Institute and associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.
The
novel drug combination allows the rapidly emerging
cancer therapies called immune checkpoint inhibitors to be incorporated into a transplant patient's
cancer treatment regimen.
Axel Huebl, who joined the team a year after Burau, has pushed the code to make optimal use of all of Titan's GPUs, winning him time on Titan through DOE's Innovative and
Novel Computational Impact on Theory and Experiment (INCITE) program for his PhD research on laser - driven radiation
therapy of
cancer.
«We are currently identifying the genes responsible for generating the DNA tether, which could be promising
novel targets for the next generation of
cancer therapies.»
Moffitt
Cancer Center researchers are leading the way in the creation of
novel therapies.
New studies from the Abramson
Cancer Center of the University of Pennsylvania are providing fresh clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic c
Cancer Center of the University of Pennsylvania are providing fresh clues on potentially effective combinations with CAR T
therapy in brain
cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic c
cancer as well as a
novel therapeutic target in head and neck
cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic c
cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic
cancercancer.
«This will help us better understand the biology of
cancer, guide therapeutic decisions and develop
novel therapies.»
Their findings, to be published in the July issue of the journal
Cancer Cell, could explain why some tumors don't respond to radiation or chemotherapy, and provide
novel routes for the development of new anti-
cancer therapies.
The Department of Translational Hematology and Oncology Research (THOR) conducts
cancer research to develop and make available
novel diagnostic tools, targeted
therapies and clinical trials for direct use in patient care.
In my role as a Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Professor of Medicine and Director of Early Phase Clinical Trials Program in the Department of Medicine at Roswell Park Comprehensive
Cancer Center, I am developing novel therapies for patients with c
Cancer Center, I am developing
novel therapies for patients with
cancercancer.
We provide access to the latest medicines and technology, as well as the most advanced clinical trials including
novel personalized targeted
therapies including precision medicine and immunotherapy - some that are only offered at NCI - designated Comprehensive
Cancer Centers like ours.
For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a
novel form of
cancer therapy that has transformed the landscape of
cancer treatment.
The work being done by scientists at Longevica may lead to a
novel approach in
cancer therapy that can significantly improve the efficiency of the current methods of
cancer treatment.
Major focus areas include human genome interpretation and genetic dissection of
novel rare diseases, predictive genomic signatures of response to
therapy — especially
cancer therapy, and
novel sequencing - based assays as biomarkers of disease.
«Dr. Meyers» research is a perfect example as to how fundamental laboratory studies are leading to innovative and
novel therapies for breast
cancer treatment,» says Dr. Raymond Hohl, director of the Penn State Hershey Cancer Inst
cancer treatment,» says Dr. Raymond Hohl, director of the Penn State Hershey
Cancer Inst
Cancer Institute.
Drug - repositioning opportunities for
cancer therapy:
novel molecular targets for known compounds.
More recently, he has focused on triple - negative breast
cancer, the role of micro-RNAs in
cancer growth and metastasis, tumor heterogeneity and
novel approaches to targeting
therapy - resistant breast
cancers.
Through understanding the biology of
cancer cells and their interaction with the immune system we are able to discover and trial
novel therapies to induce the immune system to detect and fight
cancer cells.
GigaGen's proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of
novel antibody
therapies for patients with
cancer and immune deficiency diseases.
These combined clinical and laboratory resources accelerate the development of
novel therapeutics, including immune
therapies — resulting in optimized, personalized
cancer treatments.
The South Florida Bone Marrow / Stem Cell Transplant Institute is now running a new clinical trial protocol (08001 - BMSCTI) for investigating a
novel cancer therapy using transfusions of white blood cells from healthy donors.
These
therapies are now being tested in various type of
cancer and
novel combination approaches are being developed at a very fast pace.
The Maharaj Institute has an FDA IND clinical trial protocol (08001 - BMSCTI) for investigating a
novel cancer therapy using transfusions of white blood cells from healthy donors to patient with advanced solid tumors.
This strategy is therefore a potential
novel cancer therapy.
«RapidCaP, a
novel GEM model for analysis and
therapy of metastatic prostate
cancer reveals Myc as a driver of Pten - mutant metastasis» appears online in Cancer Discovery on January 21,
cancer reveals Myc as a driver of Pten - mutant metastasis» appears online in
Cancer Discovery on January 21,
Cancer Discovery on January 21, 2014.
The results of her project will help scientists develop
novel therapies to target the regulatory proteins that cause CD47 overproduction in leukemia and other
cancer stem cells, with the goal of restoring immunosurveillance and enabling the immune system to recognize and destroy these aberrant
cancer cells.
Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine
Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid
Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid
Cancer Management:
Novel Therapeutics and Management Options Targeting Radionuclide
Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
Christopher Flowers, M.D. Emory University Microsimulation modeling to evaluate the clinical effectiveness of
novel cancer therapies